Drug Shortage Report for SODIUM THIOSULFATE INJECTION USP

Last updated on 2022-10-11 History
Report ID 163673
Drug Identification Number 02428393
Brand name SODIUM THIOSULFATE INJECTION USP
Common or Proper name Sodium Thiosulfate Injection USP
Company Name HOPE PHARMACEUTICALS LTD
Market Status MARKETED
Active Ingredient(s) SODIUM THIOSULFATE
Strength(s) 250MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 x 50 mL Vials
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-06-29
Estimated end date
Actual end date 2022-09-30
Shortage status Resolved
Updated date 2022-10-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 422 RICHARDS STREET
VANCOUVER, BRITISH COLUMBIA
CANADA V6B 2Z4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-10-11 French Compare
v7 2022-10-11 French Compare
v6 2022-10-11 English Compare
v5 2022-06-30 English Compare
v4 2022-06-29 English Compare
v3 2022-06-29 French Compare
v2 2022-06-29 English Compare
v1 2022-06-29 English Compare

Showing 1 to 8 of 8